INTRODUCTION
In adult men and women, low lung function is a major predictor of mortality, even in nonsmokers and in those without symptoms of lung disease (1, 2) . Although many authors have linked this to forced expiratory volume in 1 second (FEV1) and airflow obstruction, more recent work has shown that the strong association is between mortality and forced vital capacity (FVC), rather than airflow obstruction (1, 3) . Multiple risk factors for low lung function have been put forward, including early life exposures, lifestyle factors (mainly smoking), environmental and occupational exposures, and the presence of asthma at any point during lifetime (4) . These may operate by causing poor lung development in utero or during childhood, leading to failure to achieve maximal lung function early in life, or through more rapid decline in lung function with age during adulthood.
Differences in lung development and lung function between males and females are present throughout the life course and have been attributed to sex-specific responses to environmental or lifestyle insults and to effect of sex hormones (5, 6) . Menopause, the cessation of menstruation, usually in response to a natural age-related decline in sex hormones commonly occurs between 45 and 55 years of age, although there is considerable variation (7, 8) .
Cessation of menstruation is sometimes precipitated by surgical interventions such as oophorectomy and hysterectomy. In young women, these interventions may prompt the prescription of hormone replacement therapy (HRT).
The cessation of menstruation has been examined in relation to several chronic diseases and health parameters, but little is known about its effect on lung function. Epidemiologic evidence on the association of menopause with lung function is limited, conflicting, inconclusive, and based largely on underpowered cross-sectional studies. In two studies with a combined total of less than 3300 women, the European Community Respiratory Health Survey II and the Mater University of Queensland Study of Pregnancy, menopause was 3 associated with both lower FEV1 and FVC (9, 10) . In a smaller study, the Isparta Menopause and Health Study, menopause was associated with lower FEV1 and FVC, but this was explained by age, and it was not associated with airflow obstruction (11) . In contrast, another cross-sectional study of just over 3700 women from the Health Survey for England, natural and surgical cessation of menstruation were associated with less airflow obstruction and natural menopause was associated with higher FEV1, although only in women aged 55 to 64 (12) .
Most women undergo natural menopause, i.e. natural cessation of menstruation, around the age of 50 years (8) , which means that with increasing life expectancy they will spend a large part of their lives in a postmenopausal state. Thus, it is important to expand our understanding of the impact that menopause and other types of cessation of menstruation have on the lung.
The aims of this study were to: 1) examine the association of lung function with natural and surgical cessation of menstruation in the population-based sample of the UK Biobank; and 2) assess whether lower lung function is associated with earlier age at natural menopause.
METHODS

Study participants
UK Biobank is a very large multi-centre population-based study, established to allow the identification and improved understanding of the genetic and non-genetic determinants of disease in middle-aged and elder adults (13) The UK National Research Ethics Service Committee North West -Haydock approved the study, and electronic written consent from each participant was obtained.
Lung function outcomes
Lung function was assessed, in each centre, by nurses or healthcare technicians trained in spirometry following a standard protocol and using a Vitalograph Pneumotrac 6800 spirometer (Vitalograph Ltd., Buckingham, UK). Participants did not perform spirometry if they answered 'yes' or were unsure of the following: chest infection in the last month (i.e., influenza, bronchitis, severe cold, pneumonia); history of detached retina; heart attack or surgery to eyes, chest or abdomen in last three months; history of collapsed lung; pregnancy (first or third trimester); and currently on medication for tuberculosis. The aim was to record two acceptable blows from a maximum of three attempts. The spirometer software compared the acceptability of the first two blows and, if acceptable (defined as a ≤ 5% difference in FVC and FEV1), indicated to the fieldworkers that the third blow was not required. Postbronchodilator measurements were not performed. Analyses in this report were conducted using data from women who had provided at least two spirograms complying with the following criteria: 1) without cough; 2) back-extrapolated volume <5% FVC (or <150mL if greater); 3) flow <25mL in final 1s of forced expiratory time (FET); 4) both FEV1 and FVC reproducible; and 5) FET ≥6s on best curve (highest FEV1+FVC) (figure 1).
Outcome measures were: i) FVC; ii) FEV1; iii) spirometric restriction, defined as 
Menstrual status
Menstrual status was considered in six groups (regular menstruation; irregular menstruation; natural menopause; hysterectomy only; oophorectomy only; oophorectomy + hysterectomy) and their definition was based on a series of questions. Women who replied 'no' to the question "have you had your menopause (periods stopped)?" were also asked "how many days is your usual menstrual cycle?" If they provided a number to this question, they were classified as having 'regular menstruation' (median menstrual cycle length was 28 days, IQR [25] [26] [27] [28] . If they chose the option 'irregular cycle' they were classified as having 'irregular menstruation'.
Women were considered to have had 'natural menopause' if they replied 'yes' to the question on menopause and 'no' to both "have you had both ovaries removed?" (oophorectomy) and "have you had a hysterectomy (womb removed)?" (hysterectomy). Those whose ovaries and/or uterus were removed after their natural cessation of menstruation were classified has having had 'natural menopause'. Women were classified into three other groups depending on the type of surgical cessation of menstruation: 'hysterectomy only'; 'oophorectomy only'; and 'oophorectomy+hysterectomy'. Women unsure whether they had menopause were excluded from the analysis.
Statistical analysis
Following exclusions of women who had used an inhaler in the last hour prior to spirometry, women unsure whether they had menopause, those who were pregnant or reported a history of gynaecological cancer, and those who had reported an age at menopause less than 35 or greater than 65, the final sample for analysis comprised of 141,076 women. The association of lung function with natural menopause was further assessed by age group (age quintiles among women who had ceased menstruating) and according to age at menopause [<45 years (10%), 45-47 years (15%), 48-53 years (50%), 54-55 years (15%), 56+ years (10%)], with natural menopause between the age of 48 and 53 as reference. In order to examine whether surgical cessation of menstruation is worse than natural cessation, similar analyses were carried out for hysterectomy only and oophorectomy+hysterectomy among women who have never taken HRT. These analyses were not carried out for women who had had an oophorectomy only due to the small size of this group (n=214).
Results were considered statistically significant when P was less than 0.05. Statistical analysis was performed using Stata v.14 (StataCorp LP, College Station, TX).
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RESULTS
Characteristics of the 141,076 women included in this study are shown in table 1. As compared to women with regular or irregular menstruation, women who had stopped menstruating were older, more likely to be ex-smokers, and less likely to have ever used a contraceptive pill. More than two thirds of the women who had had surgical cessation of menstruation were ex-or current users of HRT. Ever users of HRT were more likely to be ever smokers and heavier than those who have never taken HRT (supplementary table 1 ).
The prevalence of spirometric restriction was higher in women who had stopped menstruating, while the prevalence of airflow obstruction was slightly higher in women still menstruating. Both FEV1 and FVC were lower in women who had stopped menstruating.
Just over half of the women who had natural menopause reported their last menstruation to have occurred at an age between 48 and 53 years. Most women who had undergone surgical cessation of menstruation, had their surgical intervention before they were 48 years of age (supplementary figure 1) .
Women excluded from the analyses due to low quality of spirometric data were similar to those included (supplementary table 2 ). 
Association of lung function with natural cessation of menstruation
DISCUSSION
In this population-based study of adult women, lower FVC and an increased risk of spirometric restriction were associated with natural and surgical cessation of menstruation, as compared with regular menstruation. The associations with natural menopause were stronger among women who ceased menstruating at an earlier age. These findings were unlikely to be confounded by smoking as they were observed in women who were lifetime non-smokers.
The strengths of our study are: 1) a very large sample size, which allows for more precise effect estimates; 2) the use of a standardised questionnaire for collection of data and protocol for spirometry across sites; 3) the use of spirometric measurements with the best quality only; and 4) the adjustment of models for a large set of confounders, including reproductive and lifestyle-related characteristics.
Our study also has limitations. As with all cross-sectional studies, we are unable to draw firm conclusions in terms of temporality. However, we think it is unlikely that low lung function leads to menopause. We are aware that women who smoke tend to have earlier menopause (15) , and also low lung function, but as the study is of considerable size, we were able to restrict analyses to a large group of women who have never smoked and see that our findings were unaltered. Both lung function later in life and age at menopause have been associated with socioeconomic status in childhood (16, 17) , but we do not have this information. We have adjusted for the Townsend deprivation index of place of residence at the time of assessment. Some women were unsure whether they were menopausal or not, and they were excluded from all analyses. It is difficult to predict how the inclusion of these women would affect our results, but since they were likely perimenopausal ( Endometriosis, an indication for oophorectomy without hysterectomy in young women, has been associated with asthma, but this condition was rare (<2.5%) in women who had both ovaries removed. At the assessment centres, spirometry testing did not follow the ATS/ERS recommendation of performing at least three manoeuvres to measure FVC and FEV1, but we have used only spirometric data that fulfilled all other between-and within-manoeuvre criteria (18) . Because we used pre-bronchodilator instead of post-bronchodilator spirometry,
we were unable to distinguish COPD from asthma based on lung function. However, the association of airflow obstruction with cessation of menstruation was null. Some could argue that our results may be dependent on the reference equations we used (NHANES), but we obtained very similar results using the Global Lungs Initiative equations (19) (data not shown).
To date, this is by far the largest population-based study to assess the association between Supplementary table 1 shows that ever users of hormonal replacement therapy (HRT) were more likely to be ever smokers and heavier than those who have never taken HRT.
Supplementary table 2 summarizes the characteristics of women from UK Biobank excluded from this study due to low quality of spirometry, and shows that these women were similar to those included in this analyses.
Supplementary table 3
shows how the differences in lung function between women who had undergone either natural or surgical cessation of menstruation and women still menstruating are explained by demographic (model 1), plus reproductive (model 2), and lifestyle-related characteristics (model 3).
Supplementary table 4
shows that our main findings are unlikely to be confounded by ethnicity, smoking status, body mass index (BMI), asthma, COPD, or use of HRT. The exception to this is the association of airflow obstruction (FEV1/FVC<LLN) with hysterectomy with or without oophorectomy which seems to be explained by smoking, BMI, and use of HRT.
Supplementary table 5
shows that among postmenopausal women, the earlier they underwent natural menopause, the lower their FVC. This finding is unlikely to be affected by HRT, smoking or BMI.
Supplementary table 6
shows that among postmenopausal women, the earlier they underwent natural menopause, the lower their FEV1. This finding is unlikely to be affected by HRT, smoking or BMI.
Supplementary table 7
shows that among postmenopausal women, the earlier they underwent natural menopause, the higher their risk of spirometric restriction (FVC<LLN). This finding is unlikely to be affected by HRT, smoking or BMI. 
Supplementary
Supplementary table 2.
Characteristics of women in UK Biobank excluded from this study (with at least two spirograms without cough and back-extrapolated volume <5% FVC (or <150mL if greater), but excluding those with FET ≥6s on best curve (highest FEV1 + FVC)). Women who: 1) used inhaler in the last hour; 2) were unsure whether they had menopause; 3) were pregnant; 4) had gynaecologic cancer; and 5) reported an age at menopause <35 or >65 are not included. 
Supplementary table 4.
Association of lung function with menstrual status, after sensitivity analysis. p-trend = 0.6 p-trend = 0.7 p-trend = 0.5 p-trend = 0.6 Model 3: Adjusted for centre, age, ethnicity, standing height, Townsend deprivation index, age at menarche, oral contraceptive use, hormone replacement therapy use, number of live births, smoking status, pack-years, and body mass index. Reference group: Women with natural menopause at age 48-53. P-trend is from model with age at menopause as continuous variable.
